~~<i id='C393B44B9D'><strike id='C393B44B9D'><tt id='C393B44B9D'><pre id='C393B44B9D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

fashion

author：Wikipedia 2025-10-01 23:02:31 - browse：7

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： 4 dead, 2 in stable condition in Philadelphia shooting: Police

Wikipedia

focus

hotspot

explore

hotspot

entertainment

SusanUlan,right,greetshergranddaughterIvy,andherdaughterJessieAnderson,atAnderson'shome.SuzanneKreit

WSS

Second xenotransplant done with gene

How AI helped researchers track recovery from depression

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

FDA panel to weigh approval of NurOwn, controversial ALS drug

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

NASA releases new images of 'fingerprint

entertainment

fashion

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

23andMe had bad news about my health. I wish a person had delivered it

Hearing on Medicare drug price negotiation gets unusually heated

Hepatitis C has a cure — but many Americans still lack access to it

Biotech stock slump in 2023: awaiting the turnaround

Affirmative action in medical school literally saved lives

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Hollywood unions extend contract negotiations for actors

CommonSpirit Health keeps growing, even as it loses money

focus

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Hearing on Medicare drug price negotiation gets unusually heated

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Lasker Awards 2023: Winners in biomedical research

4 dead, 2 in stable condition in Philadelphia shooting: Police

Readout LOUD podcast: possible new ALS drug, artificial wombs

hotspot

explore

hotspot

entertainment